SCHEMBL2234117

SCHEMBL2234117

CC(F)C(F)COc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.59
▸ MAOA P21397 1/20 0.53
▸ PTGS1 P23219 1/20 0.53
▸ CYP2D6 P10635 4/20 0.47
▸ MTNR1A P48039 3/20 0.47
▸ MTNR1B P49286 3/20 0.47
▸ ADRB2 P07550 1/20 0.47
▸ ADRB1 P08588 1/20 0.47
▸ ADRB3 P13945 1/20 0.47
▸ SCN4A P35499 2/20 0.47
▸ KCNA3 P22001 1/20 0.43
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ MTOR P42345 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27688895 0.82 LMNA (0.52) LMNAMAOAPTGS1CYP2D6MTNR1A
SCHEMBL1854910 0.80 SLC6A2 (0.51) LMNAPTGS1CYP2D6ADRB2ADRB1
SCHEMBL9497769 0.79 LMNA (0.48) LMNAMAOAPTGS1CYP2D6MTNR1A
SCHEMBL9229780 0.78 LMNA (0.56) LMNAMAOAPTGS1CYP2D6MTNR1A
SCHEMBL14954600 0.78 LMNA (0.56) LMNAMAOAPTGS1CYP2D6MTNR1A
SCHEMBL97377 0.78 LMNA (0.68) LMNAMAOAPTGS1CYP2D6MTNR1A
SCHEMBL13385106 0.78 LMNA (0.68) LMNAMAOAPTGS1CYP2D6MTNR1A
SCHEMBL9178337 0.78 LMNA (0.68) LMNAMAOAPTGS1CYP2D6MTNR1A
SCHEMBL27864161 0.78 LMNA (0.47) LMNAMAOAPTGS1CYP2D6MTNR1A
Ammonia Solution, Strong SCHEMBL28834669 0.76 LMNA (0.65) LMNAMAOAPTGS1CYP2D6MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102603496-A Method for synthesizing 1-butoxy-2,3-difluorobenzene PANJIN XINGFU CHEMICAL CO LTD 2012-07-25 — — CN claimed
US-9777216-B2 Liquid crystalline medium MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2017-10-03 — — US disclosed
CN-102753653-B Liquid crystal media 默克专利股份有限公司 2016-11-23 — — CN disclosed
EP-2534223-B1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2015-10-21 — — EP disclosed
EP-2534223-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2012-12-19 — — EP disclosed
US-20120305843-A1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-12-06 — — US disclosed
CN-102753653-A Liquid crystalline medium MERCK PATENT GMBH 2012-10-24 — — CN disclosed
CN-102603496-A Method for synthesizing 1-butoxy-2,3-difluorobenzene PANJIN XINGFU CHEMICAL CO LTD 2012-07-25 — — CN disclosed
WO-2011098224-A1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2011-08-18 — — WO disclosed
CN-1966482-B Preparation method of liquid crystal compound containing cyclohexyl and lateral o-difluoro-benzene VALIANT FINE CHEMICALS CO LTD YANTAI 2010-05-12 — — CN disclosed
CN-100584814-C Method for preparing difluoro alkyl ether benzene KANGPENG CHEMICAL CO LTD SHANGHAI 2010-01-27 — — CN disclosed
CN-101003468-A Method for preparing difluoro alkyl ether benzene KANGPENG CHEMICAL CO LTD SHANG (CN) 2007-07-25 — — CN disclosed
CN-1966482-A Preparation method of cyclohexyl-containing lateral o-difluorobenzene liquid crystal compound VALIANT FINE CHEMICALS CO LTD (CN) 2007-05-23 — — CN disclosed
CN-1948251-A Preparation method of 2,3-difluoro alkoxy benzene SHANGHAI KANGPENG CHEMICAL CO (CN) 2007-04-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120305843-A1 LIQUID CRYSTALLINE MEDIUM NEFM, VIM, PLG LMNA 97/4885MAOA 1008/4885PTGS1 866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback